RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Chandravanu Dash to Protein Binding

This is a "connection" page, showing publications Chandravanu Dash has written about Protein Binding.
Connection Strength

0.217
  1. Dash C, Sastry M, Rao M. Illustration of HIV-1 protease folding through a molten-globule-like intermediate using an experimental model that implicates alpha-crystallin and calcium ions. Biochemistry. 2005 Mar 15; 44(10):3725-34.
    View in: PubMed
    Score: 0.050
  2. Dash C, Yi-Brunozzi HY, Le Grice SF. Two modes of HIV-1 polypurine tract cleavage are affected by introducing locked nucleic acid analogs into the (-) DNA template. J Biol Chem. 2004 Aug 27; 279(35):37095-102.
    View in: PubMed
    Score: 0.048
  3. Dash C, Vathipadiekal V, George SP, Rao M. Slow-tight binding inhibition of xylanase by an aspartic protease inhibitor: kinetic parameters and conformational changes that determine the affinity and selectivity of the bifunctional nature of the inhibitor. J Biol Chem. 2002 May 17; 277(20):17978-86.
    View in: PubMed
    Score: 0.041
  4. Dash S, Balasubramaniam M, Rana T, Godino A, Peck EG, Goodwin JS, Villalta F, Calipari ES, Nestler EJ, Dash C, Pandhare J. Poly (ADP-Ribose) Polymerase-1 (PARP-1) Induction by Cocaine Is Post-Transcriptionally Regulated by miR-125b. eNeuro. 2017 Jul-Aug; 4(4).
    View in: PubMed
    Score: 0.030
  5. Nair GR, Dash C, Le Grice SF, DeStefano JJ. Viral reverse transcriptases show selective high affinity binding to DNA-DNA primer-templates that resemble the polypurine tract. PLoS One. 2012; 7(7):e41712.
    View in: PubMed
    Score: 0.021
  6. Ehteshami M, Scarth BJ, Tchesnokov EP, Dash C, Le Grice SF, Hallenberger S, Jochmans D, G?tte M. Mutations M184V and Y115F in HIV-1 reverse transcriptase discriminate against "nucleotide-competing reverse transcriptase inhibitors". J Biol Chem. 2008 Oct 31; 283(44):29904-11.
    View in: PubMed
    Score: 0.016
  7. Pandhare J, Dash C, Rao M, Deshpande V. Slow tight binding inhibition of proteinase K by a proteinaceous inhibitor: conformational alterations responsible for conferring irreversibility to the enzyme-inhibitor complex. J Biol Chem. 2003 Dec 05; 278(49):48735-44.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support